These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31941467)

  • 1. Prognostic factors of patients with Gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas.
    Liang J; Lv X; Lu C; Ye X; Chen X; Fu J; Luo C; Zhao Y
    BMC Cancer; 2020 Jan; 20(1):35. PubMed ID: 31941467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of patients with multifocal glioblastoma: a case-control study.
    Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
    J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased BRMS1L expression is correlated with glioma grade and predicts poor survival in glioblastoma via an invasive phenotype.
    Lv J; Yang H; Wang X; He R; Ding L; Sun X
    Cancer Biomark; 2018; 22(2):311-316. PubMed ID: 29660900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
    Weng W; Chen X; Gong S; Guo L; Zhang X
    Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases.
    Qin JJ; Liu ZX; Wang JM; Du J; Xu L; Zeng C; Han W; Li ZD; Xie J; Li GL
    Asian Pac J Cancer Prev; 2015; 16(3):971-7. PubMed ID: 25735391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for glioblastoma therapy associated complications.
    Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
    Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging correlates of survival in patients with high-grade gliomas.
    Pope WB; Sayre J; Perlina A; Villablanca JP; Mischel PS; Cloughesy TF
    AJNR Am J Neuroradiol; 2005; 26(10):2466-74. PubMed ID: 16286386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.
    Yang F; Yang P; Zhang C; Wang Y; Zhang W; Hu H; Wang Z; Qiu X; Jiang T
    Oncotarget; 2017 Jun; 8(26):42974-42982. PubMed ID: 28496000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    Karsy M; Guan J; Huang LE
    J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
    Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
    J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
    Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
    Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
    J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy.
    Wang PG; Li YT; Pan Y; Gao ZZ; Guan XW; Jia L; Liu FT
    J Neurooncol; 2019 Jan; 141(1):71-81. PubMed ID: 30446901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
    Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
    Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
    World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors of patients with unresectable glioblastoma multiforme.
    Fazeny-Dörner B; Wenzel C; Veitl M; Piribauer M; Rössler K; Dieckmann K; Ungersböck K; Marosi C
    Anticancer Drugs; 2003 Apr; 14(4):305-12. PubMed ID: 12679735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.